Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from SCRIP

13:52 EST 21st January 2019 | BioPortfolio

Here are the most relevant search results for "SCRIP" found in our extensive news archives from over 250 global news sources.

More Information about SCRIP on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SCRIP for you to read. Along with our medical data and news we also list SCRIP Clinical Trials, which are updated daily. BioPortfolio also has a large database of SCRIP Companies for you to search.

Showing News Articles 1–25 of 3,000+ from SCRIP

Monday 21st January 2019

Pharmacists to get new substitution powers to tackle Brexit shortage risk

In an effort to address possible serious drug shortages in the event of a no-deal Brexit, the UK government has...   

Singapore Reveals Phase-In Plans For eCTD

The Health Sciences Authority will seek industry’s feedback on the plans it has for introducing in Singapore the electronic format...    

GSK Looks For New Chair To Lead It Through New Strategic Direction

GSK’s non-exec chairman steps down from the UK firm, just a month after announcing a split that will reshape the...   

Korean Court Upholds Rituximab Ruling, Affirming Victory For Celltrion’s Truxima Biosimilar

An obstacle in Celltrion’s path to sell its rituximab biosimilar in Korea has been removed, with a court’s affirmation that...   

Lartruvo Phase III Fail Rocks Lilly Oncology Plans

It looks like the end for Latruvo after a late-stage trial in soft tissue sarcoma patients did not confirm the...    

VIDEO: Molecule Diversity Creates Developmental Challenges For Aspiring Commercial Biotechs

Speaking on the sidelines at BIO-Europe 2018, Jenifer Wheat, head of commercial development at Lonza’s mammalian and microbial MMBU, explains...    

Samsung Bioepis’ Trastuzumab Biosimilar Is Third Cleared By FDA – But The Market Hasn’t Formed Yet

Sued by Herceptin sponsor Genentech for patent infringement, Samsung Bioepis has legal hurdles to navigate before it can roll out...   

Aurobindo Acquires Seven Oncology Injectables From Spectrum

In line with its strategy to establish its presence in the US branded market, Aurobindo has through its subsidiary Acrotech...    

Into 2019: Regulatory Pressures Of The EU's Medical Device Regulation Will Spread Into Asia

The extra resources, time and expense that the EU Medical Device Regulation (MDR) will mean for companies in Europe has...   

Sunday 20th January 2019

Deal Watch: Celgene Makes Alliances With Kyn, Obsidian After Bristol Buyout

Just two weeks after agreeing on a merger with Bristol, Celgene is back at its own deal-making, signing cancer-focused R&D...   

Pipeline Watch: Phase II Results With ZGN-1061 And OMS721

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...   

Aum Bets On Asia-To-Global Oncology Model

Emerging Company Profile: Singapore-based Aum Biosciences hopes to disrupt early stage oncology drug development with an Asia-pivoted model, and the...   

Rare But Real: How One Startup Is Willing Itself To Lift China Orphan Drug Market

As a promising market for orphan drugs, China has seen several approvals in this space in the past six months...   

Keeping Track: FDA's Review Actions Carry On During Shutdown

The latest drug development news and highlights from our US FDA Performance Tracker.   

Trump’s Big Missed Opportunity: Medicare For All

With control over all branches of government, President Trump and Republicans made a choice to pursue repeal of the ACA...    

Friday 18th January 2019

Health And Wellness Industry News: Investments, Executive Moves

Lance Armstrong's VC invests in muscle-stimulation app maker; Ancient Nutrition appoints Shearson CEO; Penchienati-Bosetta heads specialized nutrition at Danone; and...  

Q4 Pharma Earnings Preview: J&J, Bristol And AbbVie

Johnson & Johnson has solid growth drivers in pharmaceuticals, but still faces an overhang related to talc controversy; Bristol's call...  

AdvaMed Code Update Focuses On Compliance Standards

AdvaMed has revised its industry Code of Ethics. The revised code, which will come into effect in 2020, includes new...   

PhRMA Adds Genentech, Gilead To Its Ranks Ahead Of House Democrats’ Drug Pricing Scrutiny

Roche, through Genentech, returns to the PhRMA fold after leaving the trade group in 2009; Gilead is a first-time member;...   

DTC Ads For Genetic Tests Increased 18-Fold Over 20 Years, Study Says

The number of direct-to-consumer advertisements for molecular-based tests rose exponentially from 1997 to 2016, according to a medical marketing analysis...   

Dark Days For Sun As Governance Saga Escalates

Allegations of corporate governance lapses continued to singe Sun, but there is little clarity on which way things are headed...    

Catalan Biotechs Boosted By International Backers

The number of foreign investors participating in Catalan biotech companies has gone from 0 to 50, and over the past...   

Novartis’ Data-Centric R&D Strategy Adds Pact With UK-based Big Data Institute

Novartis and the Big Data Institute have entered a research alliance using artificial intelligence to understand complex diseases and improve...   

VIDEO: Biotech Showcase 2019: Stem Cell Approach Shows Promise In Neurodegeneration

Recent studies have shown that mesenchymal stem cells (MSCs) hold great potential as a cell‐based therapy for a number of...   

Thursday 17th January 2019

QUOTED. Jan. 18, 2019. George Savage.

Proteus Digital Health announced a new partnership with Minneapolis-based Fairview Health Services and the University of Minnesota Health to prescribe...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks